nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP11B2—zona fasciculata of adrenal gland—adrenal gland cancer	0.143	0.187	CbGeAlD
Metoclopramide—CYP11B1—zona fasciculata of adrenal gland—adrenal gland cancer	0.143	0.187	CbGeAlD
Metoclopramide—CYP11B2—zona glomerulosa of adrenal gland—adrenal gland cancer	0.125	0.164	CbGeAlD
Metoclopramide—CYP11B1—zona glomerulosa of adrenal gland—adrenal gland cancer	0.125	0.164	CbGeAlD
Metoclopramide—CYP17A1—zona fasciculata of adrenal gland—adrenal gland cancer	0.0872	0.115	CbGeAlD
Metoclopramide—CYP17A1—zona glomerulosa of adrenal gland—adrenal gland cancer	0.0762	0.1	CbGeAlD
Metoclopramide—HTR4—adrenal cortex—adrenal gland cancer	0.0108	0.0141	CbGeAlD
Metoclopramide—HTR4—pituitary gland—adrenal gland cancer	0.00869	0.0114	CbGeAlD
Metoclopramide—HTR4—adrenal gland—adrenal gland cancer	0.00776	0.0102	CbGeAlD
Metoclopramide—CYP11B2—adrenal cortex—adrenal gland cancer	0.00606	0.00796	CbGeAlD
Metoclopramide—CYP11B1—adrenal cortex—adrenal gland cancer	0.00606	0.00796	CbGeAlD
Metoclopramide—CYP11B2—adrenal gland—adrenal gland cancer	0.00437	0.00575	CbGeAlD
Metoclopramide—CYP11B1—adrenal gland—adrenal gland cancer	0.00437	0.00575	CbGeAlD
Metoclopramide—CYP2D6—urine—adrenal gland cancer	0.00403	0.0053	CbGeAlD
Metoclopramide—CYP17A1—adrenal cortex—adrenal gland cancer	0.0037	0.00486	CbGeAlD
Metoclopramide—CYP17A1—gonad—adrenal gland cancer	0.00307	0.00403	CbGeAlD
Metoclopramide—CYP17A1—adrenal gland—adrenal gland cancer	0.00267	0.00351	CbGeAlD
Metoclopramide—CYP11B2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00173	0.00722	CbGpPWpGaD
Metoclopramide—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00172	0.00718	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00166	0.00693	CbGpPWpGaD
Metoclopramide—HTR4—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00159	0.00667	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00156	0.00654	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0015	0.00628	CbGpPWpGaD
Metoclopramide—CYP11B1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00149	0.00622	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00148	0.00618	CbGpPWpGaD
Metoclopramide—DRD2—pituitary gland—adrenal gland cancer	0.00144	0.00189	CbGeAlD
Metoclopramide—HTR4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00142	0.00594	CbGpPWpGaD
Metoclopramide—CYP17A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00139	0.00582	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00134	0.00561	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00133	0.00555	CbGpPWpGaD
Metoclopramide—CYP11B1—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.0013	0.00545	CbGpPWpGaD
Metoclopramide—CYP11B1—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.00129	0.00539	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00101	0.00425	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00101	0.00423	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000993	0.00416	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000936	0.00392	CbGpPWpGaD
Metoclopramide—CYP11B1—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.00093	0.00389	CbGpPWpGaD
Metoclopramide—CYP11B2—Biological oxidations—POMC—adrenal gland cancer	0.000917	0.00384	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000898	0.00376	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000884	0.0037	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—GNAS—adrenal gland cancer	0.000859	0.00359	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00085	0.00356	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GNRHR—adrenal gland cancer	0.000838	0.00351	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000835	0.00349	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000823	0.00344	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—SDHB—adrenal gland cancer	0.00082	0.00343	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000804	0.00336	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000795	0.00332	CbGpPWpGaD
Metoclopramide—CYP11B1—Biological oxidations—POMC—adrenal gland cancer	0.00079	0.00331	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000779	0.00326	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000773	0.00323	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000762	0.00319	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00076	0.00318	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TSHR—adrenal gland cancer	0.000758	0.00317	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000756	0.00316	CbGpPWpGaD
Metoclopramide—CYP17A1—Biological oxidations—POMC—adrenal gland cancer	0.000739	0.00309	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000733	0.00307	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000713	0.00298	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000708	0.00296	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—SDHB—adrenal gland cancer	0.000706	0.00296	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000693	0.0029	CbGpPWpGaD
Metoclopramide—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.000689	0.00288	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—SDHB—adrenal gland cancer	0.000661	0.00277	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000645	0.0027	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00063	0.00263	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000616	0.00258	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000608	0.00254	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000605	0.00253	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000601	0.00251	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000595	0.00249	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000585	0.00245	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—POMC—adrenal gland cancer	0.000578	0.00242	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000571	0.00239	CbGpPWpGaD
Metoclopramide—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000559	0.00234	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000556	0.00233	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000544	0.00228	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000542	0.00227	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—TSHR—adrenal gland cancer	0.000539	0.00226	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00053	0.00222	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—RRM1—adrenal gland cancer	0.000528	0.00221	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—SDHD—adrenal gland cancer	0.000528	0.00221	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00052	0.00218	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000518	0.00217	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000518	0.00217	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000508	0.00213	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GNRH1—adrenal gland cancer	0.000502	0.0021	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000487	0.00204	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000485	0.00203	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000478	0.002	CbGpPWpGaD
Metoclopramide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000464	0.00194	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000463	0.00194	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CDC42—adrenal gland cancer	0.000461	0.00193	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SPRY2—adrenal gland cancer	0.000459	0.00192	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—RRM1—adrenal gland cancer	0.000455	0.0019	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—SDHD—adrenal gland cancer	0.000455	0.0019	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000453	0.0019	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TSHR—adrenal gland cancer	0.000448	0.00187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—GNAS—adrenal gland cancer	0.000441	0.00184	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000437	0.00183	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000427	0.00179	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—RRM1—adrenal gland cancer	0.000426	0.00178	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—SDHD—adrenal gland cancer	0.000426	0.00178	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MEN1—adrenal gland cancer	0.000421	0.00176	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000413	0.00173	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000404	0.00169	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000397	0.00166	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000396	0.00166	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MED12—adrenal gland cancer	0.000394	0.00165	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000388	0.00162	CbGpPWpGaD
Metoclopramide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000376	0.00157	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000371	0.00155	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000352	0.00147	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000349	0.00146	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000342	0.00143	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MED12—adrenal gland cancer	0.000339	0.00142	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000327	0.00137	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000321	0.00134	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MED12—adrenal gland cancer	0.000317	0.00133	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—GNAS—adrenal gland cancer	0.000314	0.00131	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000311	0.0013	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GNRHR—adrenal gland cancer	0.000306	0.00128	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000305	0.00128	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000303	0.00127	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—POMC—adrenal gland cancer	0.000297	0.00124	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PRKACA—adrenal gland cancer	0.000287	0.0012	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000285	0.00119	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000284	0.00119	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000281	0.00118	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000277	0.00116	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TSHR—adrenal gland cancer	0.000277	0.00116	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDC42—adrenal gland cancer	0.000273	0.00114	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000268	0.00112	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000267	0.00112	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IGF2—adrenal gland cancer	0.000263	0.0011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000262	0.00109	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GNAS—adrenal gland cancer	0.00026	0.00109	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000256	0.00107	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000254	0.00106	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PRKACA—adrenal gland cancer	0.000248	0.00104	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000242	0.00101	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00024	0.001	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000238	0.000994	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000235	0.000983	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000234	0.00098	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000233	0.000976	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GNAS—adrenal gland cancer	0.000233	0.000974	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000233	0.000973	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PRKACA—adrenal gland cancer	0.000232	0.000969	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000229	0.000959	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ABCB1—adrenal gland cancer	0.000229	0.000956	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000228	0.000955	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000226	0.000947	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TERT—adrenal gland cancer	0.000219	0.000915	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000218	0.000911	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000213	0.000892	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000213	0.00089	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000212	0.000888	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000212	0.000886	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—POMC—adrenal gland cancer	0.000211	0.000884	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000208	0.000869	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000207	0.000867	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000205	0.000857	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GNAS—adrenal gland cancer	0.000201	0.00084	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0002	0.000839	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.0002	0.000836	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000199	0.000831	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ABCB1—adrenal gland cancer	0.000197	0.000824	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—BAD—adrenal gland cancer	0.00019	0.000796	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GNAS—adrenal gland cancer	0.000188	0.000785	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	0.000188	0.000785	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000186	0.000776	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCB1—adrenal gland cancer	0.000184	0.000771	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000183	0.000768	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000179	0.000748	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000177	0.000742	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—POMC—adrenal gland cancer	0.000175	0.000734	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—BRAF—adrenal gland cancer	0.000173	0.000724	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000168	0.000705	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000168	0.000702	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000168	0.000702	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	0.000163	0.000684	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000162	0.000676	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000161	0.000674	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000159	0.000664	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000158	0.000662	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—POMC—adrenal gland cancer	0.000157	0.000656	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	0.000154	0.000643	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000152	0.000636	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000149	0.000622	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000144	0.000601	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000142	0.000594	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000141	0.000588	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00014	0.000587	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000139	0.000581	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000137	0.000575	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000136	0.000568	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—POMC—adrenal gland cancer	0.000135	0.000565	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000133	0.000556	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000129	0.000539	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000128	0.000537	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—adrenal gland cancer	0.000126	0.000529	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000126	0.000528	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000126	0.000526	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000125	0.000524	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000125	0.000523	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—adrenal gland cancer	0.000125	0.000523	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000123	0.000515	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000122	0.000512	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000121	0.000504	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000119	0.000499	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000118	0.000492	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000117	0.000491	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000115	0.000482	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000115	0.000482	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000115	0.000482	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000108	0.000454	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—adrenal gland cancer	0.000108	0.000451	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—adrenal gland cancer	0.000101	0.000422	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	9.95e-05	0.000416	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EGFR—adrenal gland cancer	9.91e-05	0.000415	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	9.59e-05	0.000401	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	9.51e-05	0.000398	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	9.28e-05	0.000388	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	9.13e-05	0.000382	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	8.98e-05	0.000376	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	8.94e-05	0.000374	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	8.79e-05	0.000368	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MED12—adrenal gland cancer	8.59e-05	0.000359	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—adrenal gland cancer	8.32e-05	0.000348	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	8.29e-05	0.000347	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	8.12e-05	0.00034	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TERT—adrenal gland cancer	7.98e-05	0.000334	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	7.62e-05	0.000319	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	7.45e-05	0.000312	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	7.34e-05	0.000307	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	7.28e-05	0.000304	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	7.18e-05	0.000301	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	7.12e-05	0.000298	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	7.1e-05	0.000297	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	6.95e-05	0.000291	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BAD—adrenal gland cancer	6.95e-05	0.000291	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—adrenal gland cancer	6.4e-05	0.000268	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	6.32e-05	0.000265	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	6.26e-05	0.000262	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	6.13e-05	0.000256	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TERT—adrenal gland cancer	6.11e-05	0.000256	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	5.98e-05	0.00025	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BAD—adrenal gland cancer	5.31e-05	0.000222	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	5.2e-05	0.000218	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GNAS—adrenal gland cancer	5.08e-05	0.000212	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	4.98e-05	0.000208	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—adrenal gland cancer	4.9e-05	0.000205	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	4.84e-05	0.000202	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	4.8e-05	0.000201	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	4.74e-05	0.000198	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	4.69e-05	0.000196	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	4.59e-05	0.000192	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	4.57e-05	0.000191	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	3.62e-05	0.000151	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	3.5e-05	0.000146	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.42e-05	0.000143	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—adrenal gland cancer	3.42e-05	0.000143	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—adrenal gland cancer	3.04e-05	0.000127	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	2.77e-05	0.000116	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	2.73e-05	0.000114	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	2.71e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—adrenal gland cancer	2.33e-05	9.73e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	2.28e-05	9.53e-05	CbGpPWpGaD
